| Followers | 244 |
| Posts | 13889 |
| Boards Moderated | 0 |
| Alias Born | 05/19/2015 |
Sunday, July 17, 2022 9:32:11 AM
Just as suspected RGBP Nakedshorted over 58% Friday
https://www.otcshortreport.com/company/RGBP
2022-07-15 14,126,994 + 0 = 14,126,994 / 24,050,366 = 58.74
https://fintel.io/ss/us/rgbp
Naked short MM’s can’t stop this! Hammer time!
Emerging Therapies and Key pharma players involved by DelveInsight | Pfizer, Regeneron Pharmaceuticals, Regen BioPharma, Omidubicel and Others
https://www.marketwatch.com/press-release/acute-respiratory-distress-syndrome-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-pfizer-regeneron-pharmaceuticals-regen-biopharma-omidubicel-and-others-2022-07-13
https://www.otcshortreport.com/company/RGBP
2022-07-15 14,126,994 + 0 = 14,126,994 / 24,050,366 = 58.74
https://fintel.io/ss/us/rgbp
Naked short MM’s can’t stop this! Hammer time!
Emerging Therapies and Key pharma players involved by DelveInsight | Pfizer, Regeneron Pharmaceuticals, Regen BioPharma, Omidubicel and Others
https://www.marketwatch.com/press-release/acute-respiratory-distress-syndrome-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-pfizer-regeneron-pharmaceuticals-regen-biopharma-omidubicel-and-others-2022-07-13
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
